Growth hormone (GH)/insulin-like growth factor-1 (IGF-1)/insulin signaling is one of the most plausible biological pathways regulating aging and longevity. Previous studies have demonstrated that several single nucleotide polymorphisms (SNPs) in the GH/IGF-1/insulin signaling-associated genes influence both longevity and adult height, suggesting the possibility of a shared genetic architecture between longevity and height. We therefore examined the relationship between 30 height-associated SNPs and extreme longevity in a Japanese population consisting of 428 centenarians and 4,026 younger controls. We confirmed that height-increasing genetic scores (HGSs) constructed based on 30 SNPs were significantly associated with height in the controls (p = 6.95 × 10 -23
The human life span is a complex trait determined by both genetic and environmental factors. Previous twin and familial studies have demonstrated that heritability of human life span is estimated to be 20-30% (1, 2) , suggesting the existence of genetic variants associated with human life span and longevity. However, the genetic architecture of the human life span and longevity has not yet been fully understood.
To date, a number of theories of aging and longevity have been proposed, including free-radical (3), mitochondrial (4) , and DNAdamage (5) theories; and researchers have attempted to employ a candidate gene approach to identify the longevity-associated variants under the hypothesis that the variants of genes associated with previously proposed aging theories are associated with longevity (6, 7) . Among these theories, growth hormone (GH)/insulin-like growth factor-1 (IGF-1)/insulin signaling is one of the most plausible biological pathways regulating aging and longevity in humans (8) , because lack of such signaling is associated with extended life span in various organisms from Caenorhabditis elegans and Drosophila melanogaster to mice (9) (10) (11) . Experiments in model organisms have demonstrated that reduced GH/IGF-1/insulin signaling protects against oxidative stress (9) , tumorigenesis (12) , and insulin resistance (13) , which reduction may contribute to extended life span. Researchers therefore have attempted to elucidate the association between variants of GH/IGF-1/insulin signaling-associated genes such as IGF1R (14, 15) , GH1 (16) , GHR (14) , AKT1 (14) , PIK3CB (15) , and FOXO3 (14, (17) (18) (19) and extended life span in humans, and discovered that these variants are associated with extreme longevity. Especially, a strong association between variants of FOXO3 and longevity has been reported in multiple studies (14, (17) (18) (19) .
GH/IGF-1/insulin signaling promotes the cell growth and proliferation that contribute to increased body size (20) . Interestingly, it has been reported that individuals with a growth hormone receptor (GHR) deficiency exhibit a severely shortened stature but are protected against insulin resistance, oxidative stress, and development of cancer and type 2 diabetes, despite an increased prevalence of obesity (21) . Furthermore, prospective cohort studies demonstrated in a baseline survey that a shorter height is associated with a reduced risk of mortality (22, 23) , especially for deaths arising from non-smoking-related cancer (22) and that this association is more pronounced in the late-life stage (>96 years), suggesting that adult height is associated with extreme longevity in humans. He et al. also reported that a longevity allele of the FOXO3 gene is associated with shorter height. Another study also demonstrated that a composite insulin/IGF-1 signaling score calculated from six polymorphisms in GH/IGF-1/insulin signaling-associated genes is negatively associated with height and mortality risk in women (16) . These studies raised the hypothesis that individuals genetically predisposed to shorter height have an advantage for living longer through reduced GH/IGF-1/insulin signaling. If the hypothesis is satisfied, genetic variants strongly associated with height may contribute to longevity. Previous large-scale genome-wide association studies (GWASs) have identified a considerable number of common single nucleotide polymorphisms (SNPs) associated with adult height (24) (25) (26) , and subsequent pathway analyses have demonstrated that variants of GH/ IGF-1/insulin signaling-associated genes contribute to the variation in height in East Asians (26) . However, no studies have examined the association between these height-associated SNPs derived from GWAS and extreme longevity. Furthermore, because adult height is strongly influenced by socio-economic status and nutrition in childhood (27, 28) , which factors are closely associated with life span (29) , it is difficult to separate the effect of height itself from the effects of these confounding factors. Actually, although He et al. and Salaris et al. showed that shorter height is associated with an extended life span (22, 23) , several longitudinal studies demonstrated that taller height is associated with a lower mortality rate (30, 31) , which might be due to better medical care and nutrition during early childhood in taller individuals. Therefore, examination of the association between height-associated SNPs and longevity may clarify the causal relationship between height and longevity, because these variants theoretically are not associated with any confounding factors.
The purpose of the present study was to examine the relationship between height-associated SNPs identified in Japanese GWAS and extreme longevity in a Japanese population by performing a case-control study consisting of centenarians and younger controls. We also examined the polygenic effect of these variants on extreme longevity.
Methods

Study populations
The subjects in the present study were 438 centenarians (age range, 100-107 years; males, n = 84; females, n = 354) and 4,457 controls (age range, 40-79 years; males, n = 2,077; females, n = 2,380). Of these centenarians, 404 were participants in the Tokyo Centenarian Study that had been conducted between 2000-2002 (32) or the Japanese Semi-Supercentenarians Study between 2002-2011 (33) , and the remaining 34 centenarians had been enrolled in Gifu Prefecture, located in the central area of Honshu, the main island of Japan (6) . The control subjects consisted of the participants of three longitudinal studies. Of the controls, 2,903 were middle-aged and elderly people who had participated in a baseline survey by the National 
Genotyping and quality control
Total DNA was extracted from peripheral blood by using standard protocols with phenol-chloroform extraction and spin-columns. DNA quality was evaluated by performing agarose gel electrophoresis and spectrophotometry. We genotyped a total of 244,770 SNPs by using Infinium HumanExome BeadChip version 1.2 (Illumina, Inc., San Diego, CA) according to the manufacturer's protocol, followed by genotype calling using the GenTrain clustering algorithm (version 1.0) in the GenomeStudio (version. 2011.1; Illumina, Inc.), as described previously (37) .
Quality control was performed to remove the individuals that potentially provided a bias in analyses, as described previously (37) . Briefly, we removed the subjects with call rates of <0.98 (157 samples), either one of each pair of first-degree relatives or duplicated samples defined as identity-by-descent estimate >0.375 (166 samples), outliers in the population checked based on pairwise identityby-state distance (33 samples), and individuals with high rates of autosomal heterozygosity (>3.5 or <−3.5 standard deviation, 75 samples). We also removed the subjects with missing genotype for the SNPs that were selected in the present study as described in a later section (10 samples). After quality control, a total of 428 centenarians and 4,026 controls were available for analysis. Characteristics of the subjects after quality control are summarized in Table 1 .
SNP selection and calculation of height-increasing genetic score
We selected a total of 30 height-associated SNPs reported in GWAS of adult height in a Japanese population (24) . Of these 30 SNPs, 8 SNPs were associated with height with a genome-wide significance level at p < 5.0 × 10 -8 , whereas 17 SNPs showed a suggestively significant association at p < 1.0 × 10 -5 . The remaining five SNPs were originally reported by the GWAS in European populations, and the associations were replicated in a Japanese population with the same directions of the effects of the alleles (p < .001). Because rs756199 and rs3769528 were not included in HumanExome BeadChip version 1.2, they were replaced by rs2274432 and rs41464348, respectively, which are in relatively strong linkage disequilibrium with the original SNPs (rs2274432: r 2 = 0.712, D´ = 0.887; rs41464348: r 2 = 0.4, D´ = 0.928 in 1000 Genomes Pilot 1 CHB/JPT). All of the selected SNPs were in Hardy-Weinberg equilibrium (p > .001), and their minor allele frequency was ≥0.01 in our study population (Table 2 ).
To assess the polygenic effect of height-increasing alleles on extreme longevity and height in control subjects, we constructed the height-increasing genetic score (HGS) from 30 height-associated SNPs by adding the number of height-increasing alleles of each SNP. We also constructed a weighted HGS (wHGS) by multiplying the absolute values of the effect size of the alleles reported by Okada et al. (24) by the number of corresponding risk alleles, followed by addition of the weighted alleles. These scores were normalized to the Z-score to compare the effect of each HGS on extreme longevity.
We also selected an SNP in the FOXO3 gene to examine whether the association of this SNP with longevity and height was replicated in the population of the present study. Because the FOXO3 rs2802292, which was reported to be associated with longevity in multiple studies (18, 19) , was not included in HumanExome BeadChip version 1.2, we selected the FOXO3 rs2153960, which is in complete linkage disequilibrium with rs13217795 (r 2 = 1.0, D´ = 1.0 in 1000 Genomes Pilot 1 CHB/JPT), which is also associated with longevity in multiple populations (18, 19) . FOXO3 rs2153960 was not used for the construction of HGS.
Statistical analysis
All statistical analyses were performed by using SPSS version 23.0 (SPSS, Inc., Chicago, IL), R version 3.3.1 (R Foundation for Statistical Computing, Vienna, Austria), or PLINK version 1.07 (Massachusetts General Hospital, Boston, MA) (38) . The HardyWeinberg equilibrium exact test was performed by using the PLINK --hardy option. The associations of each SNP and HGS with extreme longevity were assessed with logistic regression analyses adjusted for sex as covariate. Linear regression analyses adjusted for age and sex were performed to examine the associations of each SNP, HGS, and wHGS with height in controls. Because height data on eight control subjects were missing, linear regression analyses were performed in 4,018 control subjects. Sex-stratified analyses were performed to assess heterogeneity of the allelic effect between men and women. The level of significance was set at p < .05.
Results
We first examined whether or not height-associated SNPs reported in previous Japanese GWAS were also associated with adult height in the control subjects of the present study. The results from the singlevariant association tests are summarized in Table 2 . Linear regression analyses adjusted for age and sex showed that 10 of 30 SNPs were associated with height at the significance level of p < .05, of which three SNPs remained significant even after Bonferroni correction in the present study (p < .0017). The direction of the allelic effect of all 30 SNPs was the same as in the previous GWAS results. Sex-stratified analyses showed that the SNPs in the EFEMP1 and ZBTB38 loci were significantly associated with height in men but not in women after Bonferroni correction (Supplementary Table S1 ).
Furthermore, we examined the association between the nonnormalized HGS and height. Figure 1 clearly shows that the increase in a score (corresponding to a height-increasing allele) was associated with taller height in a dose-response manner with a per age and sex-adjusted score increase of 0.247 cm. Significant associations were also observed when the subjects were stratified by sex (Supplementary Figure S1 ) and cohorts (Supplementary Figure S2) .
We next examined the association between height-associated SNP and extreme longevity ( Table 2 ). Logistic regression analyses adjusted for sex demonstrated that the SNPs in the ZBTB38, IHH, and ADAMTSL3 loci were associated with extreme longevity at the significance level of p < .05. Height-increasing allele frequencies of ZBTB38 rs9825379 and IHH rs16859517 were lower in centenarians, whereas that frequency of ADAMTSL3 rs4842838 was higher in centenarians. However, no SNPs were significantly associated with extreme longevity after Bonferroni correction.
Because previous studies demonstrated that SNPs in the FOXO3 gene are associated with longevity and adult height (22), we performed a replication study on the association between FOXO3 rs2153960 and extreme longevity. The association between FOXO3 rs2153960 and extreme longevity was replicated in the population of the present study, and the previously reported longevity allele was more frequent in centenarians than in the controls (odds ratio = 1.17; 95% confidence interval: 1.00-1.38; p = .048). Furthermore, longevity-associated allele in FOXO3 rs2153960 was We also examined the association of normalized HGS and wHGS with extreme longevity. Both HGS and wHGS were inversely associated with extreme longevity, and the odds ratios for an increase in the normalized Z-score were almost the same between HGS and wHGS (Table 3) . Although HGS was associated with height in both men and women, the significant associations of HGS and wHGS with extreme longevity were observed only in women.
Finally, we divided the female subjects into five groups according to their non-normalized HGS to examine the cumulative effect of these alleles on extreme longevity in women (Figure 2) . Logistic regression analysis revealed that the HGS group was significantly associated with extreme longevity (p for trend = .014), and the odds ratio for extreme longevity in the lowest HGS group (≤27) and the second lowest HGS group (28) (29) (30) relative to that in the highest HGS group (≥37) was 1.71 (95% confidence interval: 0.99-2.94; p = .056) and 1.69 (95% confidence interval: 1.04-2.75, p = .034), respectively.
Discussion
In the present study, we performed a case-control study consisting of centenarians and younger controls, and our data revealed that height-associated SNPs identified in Japanese GWAS had a cumulative influence on extreme longevity in Japanese women.
Based on the knowledge that a decrease in GH/IGF-1/insulin signaling is associated with extended life span in various organisms (9-11), candidate gene approaches have been performed to identify longevity-associated variants under the hypothesis that genetic variants in the GH/IGF-1/insulin signaling-associated gene are determinants of longevity (14) (15) (16) 18, 19) . Several studies demonstrated that genetic variants in GH/IGF-1/insulin signaling-associated genes are associated with longevity as well as with shorter height (16, 22) , highlighting the shared genetic architecture between longevity and height. However, the associations between height-associated SNPs derived from GWAS and extreme longevity have never been investigated, although these SNPs are possibly the strongest genetic predictor for height and might be involved in GH/IGF-1/insulin signaling. In the present study, we selected the 30 SNPs that were reported by GWAS of adult height in a Japanese population (24) . We validated that some of these SNPs were associated with adult height in the Japanese population with the same direction of allelic effect as seen in the previous GWAS results. Furthermore, HGS was significantly associated with height in control subjects regardless of sex and cohorts as well as with extreme longevity in women. These results suggest that height-associated SNPs identified by previous Japanese GWAS certainly influence the adult height in various Japanese populations, and plays roles in longevity in women. Furthermore, although previous studies reported contradictory results about the association between height and longevity (22, 23, 30, 31) , which difference might have been due to difficulty of adjusting potential confounders such as socio-economic and nutritional status in childhood, the present study clearly showed that genetically determined shorter adult height was associated with longevity in women, thus demonstrating a causal relationship between height and longevity.
As expected, several SNPs analyzed in the present study were located in the genes associated with GH/IGF-1/insulin signaling. For example, high mobility group AT-hook 1, encoded by the HMGA1 gene, is known to be a downstream target of the insulin receptor signaling pathway (39) , and loss of Hmga1 expression in mice induces impaired insulin signaling (40) . Indian hedgehog, encoded by IHH, is involved in the hedgehog signaling pathway, and plays a role in IGF-1 signaling and affects circulating levels of IGF-1 and insulin-like growth factor binding protein 1 (41) . Furthermore, polymorphisms in IGF1 were demonstrated to have an influence on circulating IGF-1 concentrations (42) . Although further investigations are needed to clarify the mechanisms by which these SNPs influence the extreme longevity in centenarians, it is plausible that some of these SNPs modulate GH/IGF-1/insulin signaling, cumulatively affecting the longevity phenotype.
The most plausible reason why height-increasing alleles were inversely associated with longevity is decreased mortality risk from cancer. Actually, it was reported that several loci analyzed in the present study are associated with cancer risk. For example, height-increasing allele of rs6763931 (r 2 = 0.449, D´ = 0.926 with rs9825379 analyzed in the present study) in ZBTB38 is associated Notes: CI = confidence interval, HGS = height-increasing genetic score, OR = odds ratio per Z-score, wHGS = weighted height-increasing genetic score. Boldface type indicates significance at p < .05. *Models adjusted for sex.
with increased risk of breast cancer (43) , and height-increasing allele of rs3791679 in EFEMP1 is frequently found in patients with glioma (44) . Furthermore, Khankari et al. performed meta-analyses of prospective cohort studies to evaluate the association of adult height with various cancers followed by Mendelian randomization analyses using 423 height-associated SNPs identified by the GWAS in European populations (45) . Interestingly, they demonstrated that increased risks of breast, colorectal, and lung cancer were associated with genetically predicted height, which was consistent with the result from meta-analyses of prospective studies. Because GH/ IGF-1/insulin signaling promotes cell proliferation and inhibits apoptosis in normal and cancerous cells (46) , and a high level of circulating IGF-1 is associated with increased risk for various cancers (47) , the relationship between height-associated SNPs and longevity in women may be partly explained by the decreased mortality risk for cancer due to a reduction in GH/IGF-1/insulin signaling. Although we focused on GH/IGF-1/insulin signaling as a mediator linking height to cancer and longevity, there are other possible pathways contributing to cancer incidence. For example, several SNPs analyzed in the present study are located in genes associated with transforming growth factor (TGF)-β signaling (LTBP1 and GDF5), an important pathway regulating bone development (48) . TGF-β signaling has a dual role in carcinogenesis, as it functions as both a suppressor in early stage tumors and a promoter in advanced tumors (49) . Increased TGF-β signaling is associated with taller height but may enhance tumor metastasis and invasion in advanced tumors. Furthermore, the hedgehog signaling pathway is also associated with development and tumorigenesis (50), and we analyzed several SNPs in the genes associated with this pathway (IHH and HHIP) . A recent study demonstrated that the hedgehog signaling pathway is a key one linking height to post-menopausal breast and colorectal cancer risk (51) . Therefore, not only GH/IGF-1/insulin but also other pathways such as TGF-β signaling and hedgehog signaling pathways may play important roles in the regulation of tumorigenesis and human life span.
Another possible mechanism linking height-associated SNPs to longevity is hyperinsulinemia. It is known that enhanced GH/IGF-1 signaling induces insulin resistance (52) and that GHR-deficient humans are insulin-sensitive and protected against the development of type 2 diabetes (21) . Insulin resistance and hyperinsulinemia not only lead to the development of type 2 diabetes but also induce oxidative stress (53) and tumorigenesis (54) , thus contributing to aging and various age-related diseases. Actually, although aging causes insulin resistance and hyperinsulinemia (55) , the insulin sensitivity of centenarians is comparable to that of healthy younger adults (56) . Therefore, height-associated SNPs may influence hyperinsulinemia and the development of its related diseases, eventually contributing to life span.
Although a number of GWASs were performed to identify the genetic variants associated with longevity, only SNPs in APOE locus were significantly associated with longevity at the genome-wide significance level (p < 5.0 × 10 -8 ) in multiple studies (17) , which is a strong risk factor for Alzheimer's disease (57) . Therefore, it has been hypothesized that individual differences in life span and longevity are influenced by a large number of genetic variants, each with a small effect, like those for adult height, of which heritability can be largely explained by an enormous number of common variants (25) . In the present study, although HGSs were inversely associated with extreme longevity, no SNPs were significantly associated with extreme longevity after Bonferroni correction. However, the moderate effect size for extreme longevity was observed when we compared the second lowest HGS group and the highest HGS group (odds ratio = 1.69), suggesting that the effects of these alleles on longevity were cumulative, even though each variant had only a small effect. These results support the hypothesis that the combination of multiple genetic variants, each with a small effect, explains the variance in longevity, providing us with insight into the genetic architecture of longevity.
Although HGSs were associated with extreme longevity in women, the significant association between any SNPs and HGSs were not observed for men. These results were similar to those of a previous study demonstrating that a composite insulin/IGF-1 signaling score calculated from six polymorphisms in GH/IGF-1/insulin signaling-associated genes was associated with mortality risk only in women (16) . Although it remains unknown why height-associated SNPs were not associated with extreme longevity in men, we can speculate that differences in environment and lifestyle factors between men and women might influence the sex difference in the association between these SNPs and longevity. However, the association between HGSs and height were significant in male control subjects, suggesting that these alleles might modulate GH/IGF-1/ insulin signaling even in men. Interestingly, epidemiological studies have indicated that shorter height is associated with lower incidence of coronary artery diseases (58) . Furthermore, Nelson et al. analyzed a total of 180 height-associated SNPs identified in the GWAS in European populations, and they demonstrated that the number of height-increasing alleles was inversely associated with a reduction in the risk of coronary artery diseases (59) . Because the coronary heart disease mortality risk is higher in men than in women (60), the negative effect of an increase in height on the mortality of coronary artery diseases might attenuate the beneficial effect of it on longevity in men. Nevertheless, because the sample size of male centenarians was limited in the present study, further investigation with a large sample size is needed to conclude whether or not height-associated SNPs are determinants of extreme longevity in men.
The present study has several limitations. First, the sample size of centenarians was relatively small to examine the association between SNPs with a small effect size and extreme longevity, particularly in men. Second, we did not perform a replication study to verify the associations observed in the present population, although we analyzed the SNPs that were already known to be associated with height in the Japanese population. Nevertheless, the association between height-associated SNPs and extreme longevity was observed only in the present study, but further replication studies in multiple ethnic populations should be conducted to build solid evidence.
In conclusion, the present study revealed an inverse association between height-increasing alleles and extreme longevity in Japanese women, and its effects were cumulative. These findings provide novel insight into the genetic architecture of longevity and aging.
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